Nasdaq Gnft News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Genfit (NASDAQ:GNFT – Get Free Report) and Neurocrine Biosciences (NASDAQ:NBIX – Get Free Report) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their analyst recommendations, valuation, earnings, profitability, institutional ownership, risk and dividends. Institutional & Insider Ownership 8.8% of Genfit shares are […]

Genfit (NASDAQ:GNFT – Get Free Report) and Neurocrine Biosciences (NASDAQ:NBIX – Get Free Report) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, profitability, earnings, institutional ownership, valuation and risk. Volatility and Risk Genfit has a beta of 1.08, […]

Genfit S.A. (NASDAQ:GNFT – Free Report) – Research analysts at Leerink Partnrs issued their FY2026 earnings per share (EPS) estimates for Genfit in a report issued on Monday, February 5th. Leerink Partnrs analyst T. Smith anticipates that the company will post earnings per share of ($0.67) for the year. The consensus estimate for Genfit’s current […]

Genfit (NASDAQ:GNFT – Get Free Report) and Curis (NASDAQ:CRIS – Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their risk, profitability, earnings, dividends, analyst recommendations, valuation and institutional ownership. Valuation & Earnings This table compares Genfit and Curis’ […]

HC Wainwright reaffirmed their buy rating on shares of Genfit (NASDAQ:GNFT – Free Report) in a research report released on Friday morning, Benzinga reports. HC Wainwright currently has a $11.00 target price on the stock. Genfit Price Performance GNFT stock opened at $3.43 on Friday. Genfit has a 1-year low of $2.89 and a 1-year […]